We are live on ! Find out more
HSCSW icon

HeartSciences Inc Warrant
HSCSW

3 hedge funds and large institutions have $23.2K invested in HeartSciences Inc Warrant in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

57.31% more ownership

Funds ownership: 0.83%58.15% (+57%)

7% more capital invested

Capital invested by funds: $21.8K → $23.2K (+$1.46K)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

40% less funds holding

Funds holding: 53 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
3
Holders Change
-2
Holders Change %
-40%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CS
1
Clear Street
New York
$11.8K
Citadel Advisors
2
Citadel Advisors
Florida
$9.68K -$165 -3,900 -2%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$1.7K +$332 +7,865 +25%
UBS Group
4
UBS Group
Switzerland
-$117 -3,439 Closed
Bank of America
5
Bank of America
North Carolina
-$26 -787 Closed

HSCSW Hedge Fund Activity: Q3 2024 in Review

3 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in HeartSciences Inc Warrant (HSCSW) for Q3 2024, worth a combined $23.2K — up 6.7% from $21.8K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of HSCSW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Susquehanna International Group, adding an estimated $332. The largest seller was Citadel Advisors, cutting an estimated $165.

  • 3 institutional investors held HeartSciences Inc Warrant (HSCSW) as of Q3 2024, down from 5 in Q2 2024.
  • Funds reported $23.2K of HeartSciences Inc Warrant stock for Q3 2024, up 6.7% quarter-over-quarter.
  • 0 funds opened new HeartSciences Inc Warrant positions in Q3 2024 and 2 closed out, a net change of -2 holders.
  • The largest HeartSciences Inc Warrant buyer in Q3 2024 was Susquehanna International Group, an estimated $332 added.
  • The largest HeartSciences Inc Warrant seller in Q3 2024 was Citadel Advisors, an estimated $165 sold.

Based on aggregated 13F filings for Q3 2024.